, predischarge (IHFU, in-hospital follow-up) (3.15 vs. 1.2 mV, p = 0.045, 7.53 vs. 3.8 mV, p < 0.001 and 5.63 vs. 2.44 mV, p = 0.017 for PP measurements, IHFU and AFU, respectively). There was a significant negative correlation between AS-PP and short RA dimension (RADs) (r = -0.56, p = 0.02), AS-IHFU and RA area (RAA) (r = -0.45, p < 0.05), AS-AFU and long RA dimension (RADl) (r = -0.46; p = 0.02), 48, p = 0.02), p < 0.01). There was no relationship between AS and other right heart dimensions. Conclusions: Larger RA size and low sensing dipole location were associated with lower AS amplitude in single-lead dual chamber ICD. (Cardiol J 2017; 24, 6: 671-676) 
Introduction
Sudden cardiac death is one of the most common causes of death in subjects with heart failure (HF), irrespective of its etiology [1, 2] . Introduction of implantable cardioverter-defibrillators (ICD) appeared to significantly cut mortality in this group of patients, thus implantation of ICDs became standard care in secondary and primary prevention [3, 4] . Prevalence of supraventricular tachyarrhythmias, mainly atrial fibrillation (AF), is higher among patients with HF and is associated with greater morbidity and mortality [5, 6] . AF is also one of the most frequent causes of inappropriate therapy in patients with ICDs [7, 8] . Most patients enrolled into ICD studies were implanted with single-lead devices [9, 10] . However, real life data showed that many patients, although they do not need atrial pacing, are implanted with additional atrial lead which increases specificity in arrhythmia diagnosis, but on the other hand, may be associated with significant increase in the rate of periprocedural complications [11, 12] and mortality [12] . There are some studies showing that data obtained from atrial lead may reduce rates of inappropriate therapy although most clinical trials provided mixed results in this area [13] [14] [15] .
Several automatic algorithms using atrial sensing were developed to minimize the risk of inappropriate therapy [16] [17] [18] . Employment of Biotronik's DX ICD lead systems (defibrillator leads with floating atrial sensing dipole) may reduce the rate of inappropriate therapies owing to SMART ® algorithm, so far available only in dual-lead ICDs.
We sought to determine whether right atrium (RA) size and/or atrial sensing (AS) rings position have an influence on atrial signal amplitude in patients with Biotronik's DX ICDs.
Methods

ICD implantation
Patients with sinus rhythm who met criteria for implantation of single-chamber ICD according to European Society of Cardiology/European Heart Rhythm Association guidelines were considered eligible for inclusion into the study. Procedures were performed by two experienced operators. The technique of ICD implantation with destination lead tip location (apex, septum or right ventricle outflow tract [RVOT]) was left for discretion of the operator. Periprocedural electrical parameters, i.a. preamplified atrial sensing amplitude (AS-PP, periprocedural atrial sensing), were measured with Medtronic Analyzer but achieving acceptable atrial signal was not mandatory if ventricular sensing and threshold was optimal. One type of defibrillation lead was used, Linox ProMRI S DX 65/15, i.e. single-coil active fixation lead with AS dipole located 15 cm from the lead tip. Two models of ICDs were implanted, i.e. Lumax 540 VR-T DX (patients [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and Iforia 5 VR-T DX (patients [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , due to changes with time in models availability in our center.
Radiographic assessment
To assess AS dipole location standard chest X-ray examination in standing position and during maximal inspiration was performed. The area of interest, i.e. RA and vena cava superior, was divided into 6 regions as showed in Figure 1 . Each patient was assigned to corresponding region according to localization of point lying in the middle of distance between AS rings.
Echocardiographic assessment
Echocardiographic examination was performed using Philips iE33 system (Philips Healthcare, Amsterdam, the Netherlands) during hospital stay associated with ICD implantation.
Assessment of the right ventricle. To assess right ventricular size we took the following steps: -measurement of RVOT proximal and distal dimensions (in the parasternal long-axis and short-axis views); -measurement of right ventricular basal, midcavity and longitudinal dimensions (in the apical 4-chamber view, adjusted to obtain the recommended "right ventricle-focused view").
All measurements were performed in accordance with 2010 guidelines of the American Society of Echocardiography (ASE), endorsed by the European Association of Cardiovascular Imaging (formerly European Association of Echocardiography [EAE] ) and the Canadian Society of Echocardiography (CSE) [19] .
Assessment of the right atrium. To assess RA size we took the following steps: -measurement of RA major/long (RADl) and minor/short dimensions (RADs); -measurement of RA area (RAA).
Measurements were performed in the standard apical 4-chamber view (as shown in Fig. 2 ), in accordance with 2010 ASE/EAE/CSE guidelines [19] .
Assessment of the left ventricle. For further assessment of longitudinal heart size, we additionally measured left ventricular longitudinal dimension in the standard apical 4-chamber view [20] .
ICD follow-up
Complete follow-up of ICD device with assessment of AS was conducted 2-3 days after the procedure (IHFU, in-hospital follow-up) and 3-6 months later (AFU, ambulatory follow-up) as a part of routine practice at our institution. Newer generation of ICDs used, i.e. Iforia 5 VR-T DX, has a possibility to measure the whole range of AS amplitude, while Lumax 540 VR-T DX shows maximal value of AS at 8.0 mV. To unify results AS exceeding 8.0 mV in patients with Iforia 5 VR-T DX were reported as 8.0 mV.
All patients included into the study agreed for chest X-ray examination, echocardiographic study, and periprocedural and during follow-up ICD parameters measurements, which were part of routine practice in our center.
Results
Twenty-five consecutive patients implanted with Biotronik ICD DX were included into the study. One patient died before outpatient follow-up and was not included into the final analysis. Baseline characteristic of study population (24 males, mean age 62 ± 13 years) is presented in Table 1 . In 1 patient, atrial signal amplitude was below the minimal measurable value of 0.4 mV during AFU. Periprocedural assessment of AS rings position was consistent with the results of assessment of follow-up chest X-ray and did not change significantly comparing two different body positions (horizontal during implantation vs vertical during X-ray examination). In most patients (n = 14; 58.3%), AS rings were localized in region 2 and 1 (n = 5; 28%). Details on AS rings localizations and mean atrial signal amplitude are presented in Figure 1 . We observed significantly greater AS amplitude for regions 1 and 2 when compared with other regions (in fact 3 and 4) (3.15 vs. 1.2, p = 0.045, 7.53 vs. 3.8, p < 0.001 and 5.63 vs. 2.44; p = 0.017 for periprocedural measurements, IHFU and AFU, respectively).
We found significant, negative correlation of: AS-AFU and RADl (r = -0.46; p = 0.02), AS-PP and RADs (r = -0.56, p = 0.02), AS-AFU and RADs (r = -0.48, p = 0.02), AS-IHFU and RAA (r = -0.45, p < 0.05), and AS-AFU and RAA (and r = -0.52, p < 0.01). There were no other significant correlations with other echocardiographic parameters listed in Table 1 .
When echocardiographic parameters were compared with radiographic region localization, no significant correlation with multiple right ventricular dimensions was found.
Discussion
DX system is a unique technique in the era of ICDs. Until now, we have not had any data about periprocedural approach to optimization of AS. There are also no guidelines for patient selection for single-lead dual chamber ICD system. Our study investigated a probable relationship between floating atrial dipole position, as well as RA dimensions and AS in a population of patient who received single-lead dual chamber ICD. The major finding of our study is the negative correlation between RA size and the dependence of AS amplitude and floating dipole position in the RA.
Literature in the subject is very limited. Iori et al. [21] showed stable AS during 200-day follow-up but the population of the study was limited to only 13 patients. In the largest, so far, multicenter study including 116 patients with ICD DX system, Safak et al. [22] achieved appropriate AS in 93.8% of patients. In this study, mean preamplified P-wave amplitudes ranged from 5.0 mV to 6.1 mV. In our set of patients, mean preamplified AS during the implantation procedure was 2.7 mV (0.7-6.7 mV). During follow-up, in 1 patient, despite programing maximal sensitiv- CKD -chronic kidney disease; eGFR -estimated glomerular filtration rate; NYHA -New York Heart Association; RADL -right atrium diameter long; RADs -right atrium diameter short; RAAright atrium area; RVD -right ventricle diameter; RVOT -right ventricular outflow tract; AP4C -apical 4-chamber; LVEF -left ventricular ejection fraction
Marcin Michalak et al., Atrial sensing in single-lead dual-chamber ICDS ity, we did not achieve reliable AS and the atrial channel was turned off. Supraventricular arrhythmias, mainly AF, are more common in subjects with HF and are associated with worse prognosis in this population [5, 6] . Identification of patients at risk of future thromboembolic events associated with silent AF is a challenge. Use of monitoring of atrial electrical activity offers potential opportunity to identify such patients. In the ASSERT study, including patients with dual chamber pacemakers, it was demonstrated that subclinical AF of ≥ 6 min duration was associated with 2.5-fold higher risk of stroke and systemic thromboembolism [23] . AF remains also the main cause of inappropriate therapies of ICDs [7, 8] . Proper AS plays a crucial role in both arrhythmia discrimination and supraventricular arrhythmia diagnostics. Inadequate AS may give inappropriate result of arrhythmia discrimination algorithm and trigger cardioversion delivery in case of supraventricular tachycardia. To receive adequate AS with floating dipole ICD it is advisable to use fourfold amplifier and special filtering of native signal. Enlargement of the atria was identified as a factor of higher prevalence of AF and lower likelihood of sinus rhythm restoration and maintenance [24, 25] . Former studies have shown that the size of atria is correlated with mean AS amplitude and AS stability in VDD pacemakers [26, 27] . This finding is consistent with our observations in this ICD population. It makes a paradoxical situation where the larger the atria the greater the risk of atrial undersensing and malfunction of the device. One cannot foresee the amplitude of f-wave during ICD implantation. Programing of achievably maximal sensitivity seems to be important in this population. In some patients during follow-up, loss of AS in device diagnostics may be suggestive for an AF episode.
Possible relationship between patients' height and AS amplitude was suggested [22] . In the present study, we did not find any connection between these variables. In our opinion, height may influence the choice of length of an electrode but should not have any significant impact on sensing.
Potentially useful techniques to achieve better AS owing to higher position of sensing dipole are the following: 1) using defibrillation leads with dipole located 17 cm from the tip of an electrode in enlarged hearts, 2) implantation of a lead to alternative places instead of right ventricle apex, and 3) playing with the course of an lead in RA (greater "heel" vs. more tense).
Limitations of the study
Our study has several limitations. First, the study population was relatively small, thus some analyses were underpowered to detect significant differences. We realize that results in a relatively small population sample may be significantly affected by a single measurement and there is a need for future investigation in a larger cohort of patients to better asses the relationships between atrial sensing and atrium diameter. Second, we analyzed only mean AS amplitude during normal breathing in lying position during the implantation procedure and in sitting position during predischarge and ambulatory follow-up. It is unknown whether results of AS test in different body positions would affect the results of our study. Third, standard chest X-ray examination is performed in standing position during maximal inspiration, therefore the sensing dipole position may slightly differ in different circumstances.
Conclusions
Smaller dimensions of RA and higher position of floating dipole in the RA are predictors of better AS amplitude in single-lead dual chamber ICDs.
